Navigation Links
BioElectronics Announces Publication of Patent Application
Date:2/26/2013

FREDERICK, Md., Feb. 26, 2013 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of unique inexpensive, patented, anti-inflammatory pain reliever devices, announced today that the World Intellectual Property Organization has published the International Patent Application for RF Induced Thermal Treatment of Tissue Pain.

While pulsed shortwave therapy is an established medical therapy, this patent provides for a method to subcutaneously heat body tissue, our nine (9) other approved, and eight (8) pending are for a self-contained medical device that is affixed to the body with a flexible antenna that allows the patient to move more freely.  This low power extended duration therapy is 3x's better than heating pads, 100% safer and costs less than $0.25 for overnight pain relief.

"We appreciate the importance of protecting our intellectual property throughout the world," said John Martinez , Director of Engineering at BioElectronics.  "This patent and our portfolio of patents provide confirmation of our sound science and are valuable assets in our accumulated body of knowledge."

About BioElectronics Corporation
Drugs and heat patches provide temporary minimal pain relief by simply masking it but it always comes back.  ActiPatch provides 5x better pain relief and is 100% safer than over-the-counter drugs. BioElectronics Corporation is an award winning medical device developer and manufacturer of advanced medical devices.  Its products are ActiPatch® Therapy, for over-the-counter treatment of back pain and other musculoskeletal complaints, the Allay™ menstrual cycle pain therapy, and RecoveryRx™ for surgical procedures and wound care.  The unique therapy delivery system, using patented technology, provides a cost-effective in-home option to reduce soft tissue pain and inflammation, and to accelerate healing. For more information, please see www.bielcorp.com.

Contact:

Paul Knopick
940.262.3584
pknopick@eandecommunications.com


'/>"/>
SOURCE BioElectronics Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Gro-International to Develop BioElectronics OTC Brands in European and African Markets
2. BioElectronics Expands to the Czech & Slovak Republic
3. BioElectronics Announces South Korean Patent Allowance for its Innovative OTC Pain Relief Medical Devices
4. BioElectronics Expands South America Distribution
5. BioElectronics Topical Pain Therapy Now Available Throughout Europe
6. BioElectronics Corporation Announces Initiative for UK and German Markets
7. BioElectronics Corporation Announces Indian Distributors Ecommerce Website
8. Clinical Interest in BioElectronics Products Expands to the Wound Care Market
9. BioElectronics ActiPatch Reduces Muscle Soreness in Runners
10. BioElectronics Survey Indicates a Five-Fold Superior Pain Relief Compared to OTC Pharmaceuticals
11. Tandem Diabetes Care Announces FDA Clearance of t:connect Diabetes Management Application for Use with t:slim Insulin Pump
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... 2017 Nevro Corp. (NYSE: NVRO), a global medical ... treatment of chronic pain, today reported financial results for the ... 2016 Accomplishment & Highlights: Achieved ... increase of 228% as reported, over the prior year ... of 612% over the prior year International ...
(Date:2/23/2017)... Calif. , Feb. 23, 2017 ... company focused on the development and commercialization of ... pain, announced that it will release fourth quarter ... Thursday, March 2nd, 2017. AcelRx management will host ... Time (1:30 p.m. Pacific Time) on March 2 ...
(Date:2/23/2017)... , Feb 23, 2017 ... Research and Markets has announced the ... Industry Forecast to 2025" report to their offering. ... of around 1.8% over the next decade to reach approximately $12.8 billion ... estimates and forecasts for all the given segments on global as well ...
Breaking Medicine Technology:
(Date:2/23/2017)... , ... February 23, 2017 , ... ... of Justice jointly issued a letter to withdraw previous guidance issued ... their gender identity. The guidance issued in May 2016 by the Obama Administration ...
(Date:2/23/2017)... , ... February 23, 2017 , ... ... with a clinician-based audience, will be participating in Rare Disease Day events, hosted ... D.C. In addition, Rare Disease Report, a website, weekly e-newsletter and quarterly publication, ...
(Date:2/23/2017)... , ... February 23, 2017 , ... Hamlin Dental Group ... that they are sponsoring a raffle. Throughout the month of February, patients who visit ... a gift card for a dinner for two at the Cheesecake Factory. , ...
(Date:2/23/2017)... Los Angeles, California (PRWEB) , ... February 23, ... ... for Global Sports Development will host a diverse symposium on “Doping ... School of Law and Sheppard Mullin Richter & Hampton LLP. The symposium will ...
(Date:2/23/2017)... ... 23, 2017 , ... ERT, a global data and technology ... Research, a leading clinical development service provider, has selected ERT’s Trial Oversight suite ... in part to an array of circumstances including the use of multiple data ...
Breaking Medicine News(10 mins):